<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">helmholtzeyeinstitute</journal-id><journal-title-group><journal-title xml:lang="ru">Российский офтальмологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Ophthalmological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0076</issn><issn pub-type="epub">2587-5760</issn><publisher><publisher-name>Real time Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21516/2072-0076-2023-16-3-87-93</article-id><article-id custom-type="elpub" pub-id-type="custom">helmholtzeyeinstitute-1304</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Изменение морфофункциональных параметров глаза при неоваскулярной глаукоме после витреоретинальных вмешательств</article-title><trans-title-group xml:lang="en"><trans-title>Changes in the morphofunctional parameters of the eye in neovascular glaucoma on the after vitreoretinal surgery</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4341-3572</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Файзрахманов</surname><given-names>Р. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Fayzrakhmanov</surname><given-names>R. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ринат Рустамович Файзрахманов - д-р мед. наук, профессор, заведующий кафедрой глазных болезней</p><p>ул. Нижняя Первомайская, д. 70, Москва, 105203</p></bio><bio xml:lang="en"><p>Rinat R. Fayzrakhmanov - Dr. of Med. Sci., professor, head of of chair ofophthalmology</p><p>70, Nizhnyaya Pervomaiskaya St., Moscow, 105203</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шишкин</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Shishkin</surname><given-names>M. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Михаил Михайлович Шишкин - д-р мед. наук, профессор, профессор кафедры глазных болезней1, главный офтальмолог центра офтальмологии</p><p>ул. Нижняя Первомайская, д. 70, Москва, 105203</p><p>ул. Нижняя Первомайская, д. 65, Москва, 105203</p></bio><bio xml:lang="en"><p>Mikhail M. Shishkin - Dr. of Med. Sci., professor, chair of ophthalmology, chief ophthalmologist of the ophthalmology center</p><p>70, Nizhnyaya Pervomaiskaya St., Moscow, 105203</p><p>65, Nizhnyaya Pervomaiskaya St., Moscow, 105203</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Калинин</surname><given-names>М. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Kalinin</surname><given-names>M. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Матвей Евгеньевич Калинин - аспирант кафедры глазных болезней, врач-офтальмолог центра офтальмологии</p><p>ул. Нижняя Первомайская, д. 70, Москва, 105203</p><p>ул. Нижняя Первомайская, д. 65, Москва, 105203</p></bio><bio xml:lang="en"><p>Matvei E. Kalinin - PhD student, chair of ophthalmology, ophthalmologist of the center of ophthalmology</p><p>70, Nizhnyaya Pervomaiskaya St., Moscow, 105203</p><p>65, Nizhnyaya Pervomaiskaya St., Moscow, 105203</p></bio><email xlink:type="simple">matvey.kalinin@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Павловский</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pavlovsky</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Олег Александрович Павловский - канд. мед. наук, врач-офтальмолог центра офтальмологии</p><p>ул. Нижняя Первомайская, д. 65, Москва, 105203</p></bio><bio xml:lang="en"><p>Oleg A. Pavlovsky - Cand. of Med. Sci., ophthalmologist at the ophthalmology center</p><p>65, Nizhnyaya Pervomaiskaya St., Moscow, 105203</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный медико-хирургический центр им. Н.И. Пирогова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National N.I. Pirogov Medical and Surgical Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Национальный медико-хирургический центр им. Н.И. Пирогова» Минздрава России; ИУВ ФГБУ «Национальный медико-хирургический центр им. Н.И. Пирогова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National N.I. Pirogov Medical and Surgical Center; IUV FSBI National N.I. Pirogov Medical and Surgical Center, Institute of Continuous Medical Education</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ИУВ ФГБУ «Национальный медико-хирургический центр им. Н.И. Пирогова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>IUV FSBI National N.I. Pirogov Medical and Surgical Center, Institute of Continuous Medical Education</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>11</day><month>10</month><year>2023</year></pub-date><volume>16</volume><issue>3</issue><fpage>87</fpage><lpage>93</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Файзрахманов Р.Р., Шишкин М.М., Калинин М.Е., Павловский О.А., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Файзрахманов Р.Р., Шишкин М.М., Калинин М.Е., Павловский О.А.</copyright-holder><copyright-holder xml:lang="en">Fayzrakhmanov R.R., Shishkin M.M., Kalinin M.E., Pavlovsky O.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://roj.igb.ru/jour/article/view/1304">https://roj.igb.ru/jour/article/view/1304</self-uri><abstract><p>Цель работы - оценка морфологических и функциональных параметров глазного яблока у пациентов с неоваскулярной глаукомой (НВГ) и диабетическим макулярным отеком (ДМО) после витреоретинальной хирургии (ВРХ).Материал и методы. Шестьдесят пациентов (60 глаз) в возрасте 59 ± 12 лет, в том числе 34 мужчины и 26 женщин, были разделены на три группы: 1-я группа — 19 (19 глаз) пациентов с НВГ и ДМО после ВРХ, проведенной не более года назад по поводу пролиферативной диабетической ретинопатии (ПДР). При наличии ДМО в 6-месячном послеоперационном периоде интравитреально вводили лекарственный препарат (3 загрузочные инъекции с интервалом в месяц). В анамнезе у пациентов была также факоэмульсификация катаракты (ФЭК) с имплантацией интраокулярной линзы (ИОЛ); 2-я группа (23 пациента, 23 глаза) — пациенты с первичной открытоугольной глаукомой (ПОУГ) III стадии, с продолжительностью глаукомного процесса до 5 лет, которым ранее не проводились лазерные или хирургические антиглаукомные вмешательства, — в анамнезе у этих пациентов также операция ФЭК с имплантацией ИОЛ; 3-я группа (18 пациентов, 18 глаз) — пациенты с артифакией без признаков глаукомы и другой глазной патологии (группа контроля).Результаты. Открытие угла передней камеры (УПК) при НВГ (группа 1) было в 2,73 раза меньше (p = 0,034), чем при ПОУГ (группа 2), и в 3,69 раза меньше, чем у пациентов группы контроля (p = 0,034), неоваскуляризация радужки и УПК отмечались преимущественно у пациентов с НВГ (84 %). Гониосинехии в УПК у пациентов группы 1 отмечены в 6,35 раза чаще, чем у пациентов группы 2, и в 14,45 раза чаще, чем у пациентов группы 3. Рубеоз встречался у пациентов группы 1 в 4,65 чаще, чем у пациентов группы 2 (p = 0,034), и в 6,64 раза чаще, чем у пациентов группы 3 (p = 0,034). Отмечены статистически значимые различия морфометрических параметров диска зрительного нерва в группах 1 и 2 с группой 3, а показатели группы 1 и 2 были статистически сопоставимы, что связано с одинаковой степенью тяжести глаукомного процесса в этих группах. Анализ индексов компьютерной периметрии MD, MS и sLV показал наличие развитого глаукомного процесса в группах 1 и 2. Выявленные изменения основываются на патогномоничных факторах, в частности могут быть вызваны ранее проведенным оперативным вмешательством, затрагивающим витреоретинальный интерфейс у пациентов группы 1.Заключение. Возникновение НВГ вызвано преимущественно тяжелым течением ПДР и изменением профиля УПК за счет образования синехий. Независимо от факторов риска результат оперативного лечения зависит от состояния ишемизированной сетчатки и переднего сегмента глаза. Оценка морфофункциональных параметров глаза при НВГ с ДМО после ВРХ представляет большой интерес, поскольку степень открытости УПК, расстояние от радужки до ИОЛ, наличие рубеоза и гониосинехий можно использовать для определения метода и тактики оперативного лечения, что позволит устранить патофизиологические факторы возникновения и прогрессирования НВГ и снизить частоту послеоперационных осложнений.</p></abstract><trans-abstract xml:lang="en"><p>Purpose: to assess morphological and functional parameters of the eyeball in patients with neovascular glaucoma (NVG) and diabetic macular edema (DME) after vitreoretinal interventions.Material and methods. This study involved 60 patients (60 eyes), aged 59 ± 12 including 34 men and 26 women. The patients were divided into three groups: group 1 — 19 patients (19 eyes) with NVG and DME after a vitreoretinal surgery (VRS) for proliferative diabetic retinopathy performed no earlier than a year ago. If DME was found within 6 months after the surgery, a drug was administered intravitreally (3 loading injections given with monthly intervals). The patients’ history contained cataract phacoemulsification with an implantation of an intraocular lens (IOL). Group 2 (23 patients, 23 eyes) consisted of persons with stage III primary open-angle glaucoma (POAG) with the duration of the glaucomatous process of up to 5 years, who received no laser or surgical antiglaucomatous interventions. The history of these patients also contained phacoemulsification operations with IOL implantation. Group 3 (18 patients, 18 eyes), which was composed of patients with pseudophakia but no symptoms of glaucoma or other eye pathology, served as control.Results. The opening of the anterior chamber angle (ACA) in NVG (group 1) was 2.73 times smaller (p = 0.034) than in POAG (Group 2) and 3.69 times smaller than in the control group (p = 0.034). Neovascularization of the iris and the ACA could primarily be seen in patients with NVG (84 %). Goniosynechiae in the ACA of group 1 patients were seen 6.35 times more often than in group 2 patients and 14.45 times more often than in group 3 patients. Rubeosis occurred in group 1 patients 4.65 times as often as in group 2 and 6.64 times more often than in group 3 patients (p = 0.034). Statistically significant differences of morphometric parameters of the optic disc between groups 1 and 2, on the one hand, and group 3, on the other hand were found. Meanwhile, the figures for groups 1 and 2 were statistically comparable, which is explained by the same degree of severity of the glaucomatous process in these groups. The analysis of indices of computer perimetry MD, MS and sLV showed a developed glaucomatous process in groups 1 and 2. The revealed changes are based on pathognomonic factors. In particular, they may be caused by the prior surgical intervention affecting the vitreoretinal interface in group 1 patients.Conclusion. The onset of NVG is primarily caused by a grave course of proliferative diabetic and changes in the ACA profile, due to the formation of synechiae. Regardless of the risk factors, the result of surgical treatment depends on the condition of the ischemic retina and the anterior segment of the eye. Thus, the assessment of the morphofunctional parameters of the eye in patients with NVG and DME after VRS is of great interest. Changes in such parameters as the degree of openness of the ACA, distance from the iris to the IOL, the presence of rubeosis and synechia may be used to determine the methods and tactics of surgery, which will eliminate the pathophysiological factors of the onset and progression of CVH, and reduce postoperative complications.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>неоваскулярная глаукома</kwd><kwd>первичная открытоугольная глаукома</kwd><kwd>вторичная глаукома</kwd></kwd-group><kwd-group xml:lang="en"><kwd>neovascular glaucoma</kwd><kwd>primary open-angle glaucoma</kwd><kwd>secondary glaucoma</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Нероев В.В. Анализ первичной офтальмологической медико-санитарной помощи в Российской Федерации. Российская офтальмология онлайн. 2016; 23: 23–1.</mixed-citation><mixed-citation xml:lang="en">Neroev V.V. Analysis of primary ophthalmic health care in the Russian Federation. Russian ophthalmology online. 2016; 23: 23–1 (In Russ.). Available at: https://eyepress.ru/article.aspx?22646 (Acced 5 Apr 2023).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Widder R, Lemmen KD, Dietlein T. Neovaskularisations glaukom. Klin Monatsbl Augenheilkd. 2010; 227 (2): R15–28.</mixed-citation><mixed-citation xml:lang="en">Widder R, Lemmen KD, Dietlein T. Neovaskularisations glaukom. Klin Monatsbl Augenheilkd. 2010; 227 (2): R15–28.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou MW, Xu X, Zhang XL, Sun XD. Clinical outcomes of Ahmed glaucoma valve implantation with or without intravitreal bevacizumab pretreatment for neovascular glaucoma: a systematic review and meta-analysis. J Glaucoma. 2016; 25 (7): 551–7. doi: 10.1097/IJG.0000000000000241</mixed-citation><mixed-citation xml:lang="en">Zhou MW, Xu X, Zhang XL, Sun XD. Clinical outcomes of Ahmed glaucoma valve implantation with or without intravitreal bevacizumab pretreatment for neovascular glaucoma: a systematic review and meta-analysis. J Glaucoma. 2016; 25 (7): 551–7. doi: 10.1097/IJG.0000000000000241</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Файзрахманов Р.Р., Калинин М.Е., Шишкин М.М., Павловский О.А. Современный взгляд на использование гониоассоцированной трабекулотомии. Офтальмохирургия. 2021; 3: 77–82.</mixed-citation><mixed-citation xml:lang="en">Fayzrakhmanov R.R., Kalinin M.E., Shishkin M.M., Pavlovskiy O.A. Modern view of using gonioassociated trabeculotomy. Fyodorov journal of ophthalmic surgery. 2021; 3: 77–82 (In Russ.). https://doi.org/10.25276/0235-4160-2021-3-77-82</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hayreh SS. Neovascular glaucoma. Prog Retin Eye Res. 2007; 26 (5): 470–85. doi: 10.1016/j.preteyeres.2007.06.001</mixed-citation><mixed-citation xml:lang="en">Hayreh SS. Neovascular glaucoma. Prog Retin Eye Res. 2007; 26 (5): 470–85. doi: 10.1016/j.preteyeres.2007.06.001</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Comment and response to the article “The clinical relevance of visualizing the peripheral retina” by Nicola Quinn, Lajos Csincsik, Erin Flynn, Christine A. Curcio, Szilard Kiss, SriniVas R. Sadda, Ruth Hogg, Tunde Peto Imre Lengyel. Prog Retin Eye Res. 2021; 83: 1000939 doi: 10.1016/j.preteyeres.2020.100939</mixed-citation><mixed-citation xml:lang="en">Comment and response to the article “The clinical relevance of visualizing the peripheral retina” by Nicola Quinn, Lajos Csincsik, Erin Flynn, Christine A. Curcio, Szilard Kiss, SriniVas R. Sadda, Ruth Hogg, Tunde Peto Imre Lengyel. Prog Retin Eye Res. 2021; 83: 1000939 doi: 10.1016/j.preteyeres.2020.100939</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Shazly TA, Latina MA. Neovascular glaucoma: etiology, diagnosis and prognosis. Semin Ophthalmol. 2009; 24 (2): 113–21. doi: 10.1080/08820530902800801</mixed-citation><mixed-citation xml:lang="en">Shazly TA, Latina MA. Neovascular glaucoma: etiology, diagnosis and prognosis. Semin Ophthalmol. 2009; 24 (2): 113–21. doi: 10.1080/08820530902800801</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Netland PA. The Ahmed glaucoma valve in neovascular glaucoma (an AOS thesis). Trans Am Ophthalmol Soc. 2009; 107: 325–42.</mixed-citation><mixed-citation xml:lang="en">Netland PA. The Ahmed glaucoma valve in neovascular glaucoma (an AOS thesis). Trans Am Ophthalmol Soc. 2009; 107: 325–42.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Simha A, Braganza A, Abraham L, Samuel P, Lindsley K. Anti-vascular endothelial growth factor for neovascular glaucoma. Cochrane Database Syst Rev. 2013; 10 (10): CD007920. doi: 10.1002/14651858.CD007920</mixed-citation><mixed-citation xml:lang="en">Simha A, Braganza A, Abraham L, Samuel P, Lindsley K. Anti-vascular endothelial growth factor for neovascular glaucoma. Cochrane Database Syst Rev. 2013; 10 (10): CD007920. doi: 10.1002/14651858.CD007920</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Olmos LC, Sayed MS, Moraczewski AL, et al. Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab. Eye (Lond). 2016; 30 (3): 463–72. doi: 10.1038/eye.2015.259</mixed-citation><mixed-citation xml:lang="en">Olmos LC, Sayed MS, Moraczewski AL, et al. Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab. Eye (Lond). 2016; 30 (3): 463–72. doi: 10.1038/eye.2015.259</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Neovascular glaucoma. 2018. EyeRounds.org. Available at: http://eyerounds.org/cases/268-neovascular-glaucoma.pdf (Acced 6 March 2023)</mixed-citation><mixed-citation xml:lang="en">Neovascular glaucoma. 2018. EyeRounds.org. Available at: http://eyerounds.org/cases/268-neovascular-glaucoma.pdf (Acced 6 March 2023)</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Wakabayashi Y, Usui Y, Okunuki Y, et al. Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012; 53 (10): 6403–10. doi: 10.1167/iovs.12-10367</mixed-citation><mixed-citation xml:lang="en">Wakabayashi Y, Usui Y, Okunuki Y, et al. Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012; 53 (10): 6403–10. doi: 10.1167/iovs.12-10367</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Goto A, Inatani M, Inoue T, et al. Frequency and risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy. J Glaucoma. 2013; 22 (7): 572–6. doi: 10.1097/IJG.0b013e31824d514a</mixed-citation><mixed-citation xml:lang="en">Goto A, Inatani M, Inoue T, et al. Frequency and risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy. J Glaucoma. 2013; 22 (7): 572–6. doi: 10.1097/IJG.0b013e31824d514a</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Henderer JD, Budenz DL, Flynn Ir HW, et al. Elevated intraocular pressure and hypotony following silicone oil retinal tamponade for complex retinal detachment: incidence and risk factors. Arch Ophthalmol. 1999; 117 (2): 189–95. doi: 10.1001/archopht.117.2.189</mixed-citation><mixed-citation xml:lang="en">Henderer JD, Budenz DL, Flynn Ir HW, et al. Elevated intraocular pressure and hypotony following silicone oil retinal tamponade for complex retinal detachment: incidence and risk factors. Arch Ophthalmol. 1999; 117 (2): 189–95. doi: 10.1001/archopht.117.2.189</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Resnikoff S, Pascolini D, Etya’Ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004; 82 (11): 844–51</mixed-citation><mixed-citation xml:lang="en">Resnikoff S, Pascolini D, Etya’Ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004; 82 (11): 844–51</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Fong DS, Aiello LP, Ferris FR, Klein R. Diabetic retinopathy. Diabetes Care. 2004; 27 (10): 2540–53. doi: 10.2337/diacare.27.10.2540</mixed-citation><mixed-citation xml:lang="en">Fong DS, Aiello LP, Ferris FR, Klein R. Diabetic retinopathy. Diabetes Care. 2004; 27 (10): 2540–53. doi: 10.2337/diacare.27.10.2540</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Суханова А.В., Файзрахманов Р.Р., Павловский О.А., Карпов Г.О., Босов Э.Д. Динамика параметров чувствительности центральной зоны сетчатки после витрэктомии по поводу регматогенной отслойки сетчатки с использованием силиконовой тампонады. Саратовский медицинский журнал. 2021; 17 (2): 383–7.</mixed-citation><mixed-citation xml:lang="en">Sukhanova A.V., Fayzrakhmanov R.R., Pavlovsky O.A., Karpov G.O., Bosov E.D. Dynamics of sensitivity parameters of the central retinal zone after vitrectomy for rhegmatogenous retinal detachment using silicone oil tamponade. Saratov journal of medical scientific research. 2021; 17 (2): 383–7 (In Russ.). Available at: https://ssmj.ru/en/2021/2/383</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Yau GL, Silva PS, Arrigg PG, Sun JK. Postoperative complications of pars plana vitrectomy for diabetic retinal disease. Semin Ophthalmol. 2018; 33 (1): 126–33. doi: 10.1080/08820538.2017.1353832</mixed-citation><mixed-citation xml:lang="en">Yau GL, Silva PS, Arrigg PG, Sun JK. Postoperative complications of pars plana vitrectomy for diabetic retinal disease. Semin Ophthalmol. 2018; 33 (1): 126–33. doi: 10.1080/08820538.2017.1353832</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Файзрахманов Р.Р., Суханова А.В., Павловский О.А., Ларина Е.А. Роль ОКТ-ангиографии в исследовании ретинальной перфузии после эндовитреального вмешательства по поводу регматогенной отслойки сетчатки. Клиническая практика. 2020; 11 (3): 61–7.</mixed-citation><mixed-citation xml:lang="en">Fayzrakhmanov R.R., Sukhanova A.V., Pavlovsky O.A., Larina E.A. The role of OCT angiography in a study of retinal perfusion after endovitreal intervention due to rhegmatogenous retinal detachment. Jurnal of Clinical Practice. 2020; 11 (3): 61–7 (In Russ.). doi: 10.17816/clinpract33960</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Jampol LM, Glassman AR, Sun J. Evaluation and care of patients with diabetic retinopathy. N Engl J Med. 2020; 382 (17): 1629–37. doi: 10.1056/NEJMra1909637</mixed-citation><mixed-citation xml:lang="en">Jampol LM, Glassman AR, Sun J. Evaluation and care of patients with diabetic retinopathy. N Engl J Med. 2020; 382 (17): 1629–37. doi: 10.1056/NEJMra1909637</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Коновалова К.И., Шишкин М.М., Файзрахманов Р.Р. Эффективность многоэтапного хирургического лечения пролиферативной диабетической ретинопатии, осложненной начальной катарактой. Вестник офтальмологии. 2020; 136 (6): 171–6.</mixed-citation><mixed-citation xml:lang="en">Konovalova K.I., Shishkin M.M., Fayzrakhmanov R.R. Effectiveness of multistage surgical treatment of advanced proliferative diabetic retinopathy complicated with primary cataract. Vestnik Oftal’mologii. 2020; 136 (6): 171–6 (In Russ.). https://doi.org/10.17116/oftalma2020136062171</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Senn P, Schipper I, Perren B. Combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in the capsular bag: a comparison to vitrectomy and subsequent cataract surgery as a twostep procedure. Ophthalmic Surg Lasers. 1995; 26: 420–8. https://doi.org/10.3928/1542-8877-19950901-09</mixed-citation><mixed-citation xml:lang="en">Senn P, Schipper I, Perren B. Combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in the capsular bag: a comparison to vitrectomy and subsequent cataract surgery as a twostep procedure. Ophthalmic Surg Lasers. 1995; 26: 420–8. https://doi.org/10.3928/1542-8877-19950901-09</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Stefansson E, Landers MB, Wolbarsht ML. Increased retinal oxygen supply following pan-retinal photocoagulation and vitrectomy and lensectomy. Trans Am Ophthalmol Soc. 1981; 79: 307–34.</mixed-citation><mixed-citation xml:lang="en">Stefansson E, Landers MB, Wolbarsht ML. Increased retinal oxygen supply following pan-retinal photocoagulation and vitrectomy and lensectomy. Trans Am Ophthalmol Soc. 1981; 79: 307–34.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Saito Y, Higashide T, Takeda H, et al. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab. Am J Ophthalmol. 2010; 149 (6): 964–72. doi: 10.1016/j.ajo.2010.01.008</mixed-citation><mixed-citation xml:lang="en">Saito Y, Higashide T, Takeda H, et al. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab. Am J Ophthalmol. 2010; 149 (6): 964–72. doi: 10.1016/j.ajo.2010.01.008</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
